Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Sureda, Anna
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. [electronic resource] - Haematologica Feb 2012 - 310-7 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
1592-8721
10.3324/haematol.2011.045757 doi
Adolescent
Adult
Europe
Female
Graft vs Host Disease--immunology
Hodgkin Disease--immunology
Humans
Male
Middle Aged
Prospective Studies
Secondary Prevention
Stem Cell Transplantation--methods
Survival Rate
Transplantation Conditioning--methods
Transplantation, Homologous--mortality
Young Adult
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. [electronic resource] - Haematologica Feb 2012 - 310-7 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
1592-8721
10.3324/haematol.2011.045757 doi
Adolescent
Adult
Europe
Female
Graft vs Host Disease--immunology
Hodgkin Disease--immunology
Humans
Male
Middle Aged
Prospective Studies
Secondary Prevention
Stem Cell Transplantation--methods
Survival Rate
Transplantation Conditioning--methods
Transplantation, Homologous--mortality
Young Adult